| Literature DB >> 35053786 |
Jesús Pastor1, Lorena Vega-Zelaya1, Elena Martín-Abad1.
Abstract
Deep brain stimulation (DBS) requires a precise localization, which is especially difficult at the hypothalamus, because it is usually performed in anesthetized patients. We aimed to characterize the neurophysiological properties posteromedial hypothalamus (PMH), identified by the best neurophysiological response to electrical stimulation. We obtained microelectrode recordings from four patients with intractable aggressivity operated under general anesthesia. We pooled data from 1.5 mm at PMH, 1.5 mm upper (uPMH) and 1.5 mm lower (lPMH). We analyzed 178 units, characterized by the mean action potential (mAP). Only 11% were negative. We identified the next types of units: P1N1 (30.9%), N1P1N2 (29.8%), P1P2N1 (16.3%), N1P1 and N1N2P1 (6.2%) and P1N1P2 (5.0%). Besides, atypical action potentials (amAP) were recorded in 11.8%. PMH was highly different in cell composition from uPMH and lPMH, exhibiting also a higher percentage of amAP. Different kinds of cells shared similar features for the three hypothalamic regions. Although features for discharge pattern did not show region specificity, the probability mass function of inter-spike interval were different for all the three regions. Comparison of the same kind of mAP with thalamic neurons previously published demonstrate that most of cells are different for derivatives, amplitude and/or duration of repolarization and depolarization phases and also for the first phase, demonstrating a highly specificity for both brain centers. Therefore, the different properties described for PMH can be used to positively refine targeting, even under general anesthesia. Besides, we describe by first time the presence of atypical extracellular action potentials.Entities:
Keywords: Weaver syndrome; deep brain stimulation; intractable aggressivity extracellular action potentials; microelectrode recording; psychosurgery
Year: 2021 PMID: 35053786 PMCID: PMC8773588 DOI: 10.3390/brainsci12010043
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Acronyms used along the manuscript.
| Acronym | Definition |
|---|---|
| amAP | Atypical Mean Action Potential |
| AP | Action Potential |
| BI | Burst Index |
| DBS | Deep Brain Stimulation |
| dmAP | Duration of the mean Action Potential |
| dtN/dtP | Duration of Negative/Positive phases at half-amplitude of EAP |
| dDep | Duration of the Depolarization |
| dFP | Duration of the First Phase |
| dRep | Duration of the Repolarization |
| dVmax/dVmin | Maximum/Minimum values of the first derivative |
| EAP | Extracellular Action Potential |
| Freqcell | Frequency of the individual neuron |
| Freqraw | Frequency of the raw trace |
| ISI | Inter-Stimulus Interval |
| lPMH | Lower Posteromedial Hypothalamus |
| MER | Microelectrode Recording |
| mAP | Mean Action Potential |
| MRI | Magnetic Resonance Imaging |
| N1P1 | Negative (Dep) and Positive (Rep) phases cell |
| N1P1N1 | Negative (FP), Positive (Dep) and Negative (Rep) phases cell |
| N1N2P1 | Negative (FP), Negative (Dep) and Positive (Rep) phases cell |
| PI | Pause Index |
| PMH | Posteromedial hypothalamus |
| pmf | Probability Mass Function |
| PR | Pause Ratio |
| PS | Power Spectra |
| P/N | Positive/Negative phase |
| P1N1 | Positive (Dep) and Negative (Rep) phases cell |
| P1P2N1 | Positive (FP), Positive (Dep) and Negative (Rep) phases cell |
| P1N1P2 | Positive (FP), Negative (Dep) and Positive (Rep) phases cell |
| SW | Schaltenbrand-Wahren |
| uPMH | Upper Posteromedial Hypothalamus |
| VAP± | Positive/negative voltage thresholds of mAP |
| VDep | Amplitude (voltage) of the Depolarization phase |
| VFP | Amplitude (voltage) of the Firs Phase |
| VmAP | Amplitude (voltage) of the mean Action Potential |
| Vmax/Vmin | Maximum/Minimum voltages of EAP |
| VRep | Amplitude (voltage) of the Repolarization phase |
| V± | Maximum/minimum voltage threshold |
Demographic and clinical findings.
| Patient | Age (yrs) | Sex | Intellectual Capacity | Medical History | Medication | MRI |
|---|---|---|---|---|---|---|
| 1 | 22 | F | severe mental retardation | cluster headache, epilepsy | TPM, CLZ, RIS, LVM, OLZ | moderate diffuse cortico-subcortical atrophy; pineal cyst |
| 2 | 22 | M | moderate mental retardation | perinatal hypoxia | GBP, VPA, CYP, Li, OLZ | normal |
| 3 | 48 | M | moderate mental retardation | OCD, AVM, complex partial seizure | CBM, GBP, ZPX, CTP, CLZ | extensive encephalomalacia in right temporal lobe |
| 4 | 37 | F | severe mental retardation | epilepsy | LVM, OLZ, TPM, RIS, ARP | normal |
ARP = arpiprazole; AVM = arterio-venous malformation; CBM = carbamacepine; CLZ = clorazepate; CTP = citalopram; CYP = cyproterone; GBP = gabapentine; Li = lithium; LVM = levomepromazine; MRI = magnetic resonance imaging; OCD = obsessive-compulsive disorder; OLZ = olanzapine; RIS = risperidone; TPM = topiramate; VPA = valproic acid; ZPX = zuclopenthixol.
Figure 1Sorting and analysis of AP and pattern discharge. (A) Raw recording showing EAP as vertical lines of different amplitude; (B) EAP (upper row) and first derivative (lower row) showing the definitions of variables computed for sorting; (C) clustering in different units (identified by different colors) of the raw trace. Only three dimensions are shown, although clusterization used up to 6. (D) mAP (upper row) and mean derivative of EAP (lower row) in red obtained from EAP and derivatives of EAP of similar morphology (blue lines); (E) Example of mAP showing the definition of variables analyzed. Tick dashed line represents basal voltage, and thin dotted lines represent upper and lower thresholds used to characterize the structure. Dots are the fiducial points used to define amplitudes and phases. (F) Analysis of raw trace. Upper dots in colors represent EAP grouped at the same mAP and therefore ascribed to the same cell. Superimposed are showed a binary plot (blue lines) where each line represents an EAP and a chart diagram showing the frequency measured at 1 s-bin.
Figure A1Automatic sorting of different types of canonical forms. (A) P1N1; (B) P1P2N1 and (C) N1P1N2. Blue lines are individual sorting EAP attributed to the same cluster. Red lines, mAP computed from the set of individual EAP.
Figure 2Types of normalized mAP. (A) P1P2N1, (B) N1P1N2, (C) P1N1, (D) amAP P1P2N1, (E) amAP N1P1N2, and (F) N1P1. The different phases are indicated. Dashed horizontal black line show zero voltage. (G) Raw trace 20 s duration from patient #3 lPMH (upper row). Two 1 s-spanned sections are enlarged (middle row), and APs obtained from everyone region are shown (lower row). Arrowheads denote the extended EAP.
Absolute frequency and percentage (between brackets) computed for the different types of mAP at the three regions.
| Region | Type of mAP | ||||||
|---|---|---|---|---|---|---|---|
| P1N1 | P1P2N | N1P1N2 | P1N1 | P1N1P2 | amAP | Total | |
| uPMH | 25 (36) | 9 (13) | 23 (33) | 2 (3) | 4 (6) | 7 (10) | 70 (100) |
| PMH | 12 (21) | 12 (21) | 12 (21) | 5 (9) | 4 (7) | 11 (20) | 56 (100) |
| lPMH | 18 (35) | 8 (15) | 18 (35) | 4 (8) | 1 (2) | 3 (6) | 52 (100) |
Properties of types of mAP across the three regions.
| mAP | Region | VFP | VDep | VRep | VmAP | dFP | dDep | dRep | dmAP | dVmax | dVmin |
|---|---|---|---|---|---|---|---|---|---|---|---|
| uPMH | - | 45.5 ± 3.1 | −25.5 ± 1.6 | 71.4 ± 3.7 | - | 0.43 ± 0.02 | 1.16 ± 0.08 | 1.59 ± 0.08 | 3.4 ± 0.3 | −3.3 ± 0.3 | |
| P1N1 | PMH | - | 50.6 ± 9.0 | −33.7 ± 5.1 | 84.3 ± 13.8 | - | 0.47 ± 0.03 | 1.20 ± 0.08 | 1.66 ± 0.08 | 3.5 ± 0.5 | −3.8 ± 0.8 |
| lPMH | - | 43.5 ± 2.2 | −28.4 ± 2.1 | 71.9 ± 3.8 | - | 0.47 ± 0.02 | 0.94 ± 0.03 | 1.41 ± 0.02 | 2.7 ± 0.2 | −3.4 ± 0.3 | |
| uPMH | 11.3 ± 3.0 | 41.8 ± 4.1 | −27.4 ± 2.9 | 69.3 ± 6.8 | 0.25 ± 0.02 | 0.38 ± 0.02 | 0.91 ± 0.11 | 1.54 ± 0.12 | 2.9 ± 0.4 | −3.7 ± 0.5 | |
| P1P2N1 | PMH | 18.8 ± 3.4 | 50.3 ± 7.1 | −31.7 ± 3.8 | 82.0 ± 10.5 | 0.28 ± 0.02 | 0.37 ± 0.01 | 1.39 ± 0.09 | 2.04 ± 0.10 | 2.4 ± 0.5 | −3.5 ± 0.5 |
| lPMH | 8.8 ± 1.4 | 38.9 ± 7.1 | −32.4 ± 5.8 | 71.2 ± 12.8 | 0.25 ± 0.03 | 0.38 ± 0.02 | 1.04 ± 0.09 | 1.64 ± 0.11 | 2.2 ± 0.4 | −3.0 ± 0.7 | |
| uPMH | −9.0 ± 1.1 | 54.2 ± 7.0 | −33.2 ± 2.6 | 87.4 ± 9.1 | 0.28 ± 0.03 | 0.39 ± 0.02 | 1.11 ± 0.10 | 1.79 ± 0.10 | 4.6 ± 0.6 | −4.1 ± 0.4 | |
| N1P1N2 | PMH | −9.6 ± 1.8 | 45.8 ± 7.4 | −25.2 ± 2.1 | 71.0 ± 8.9 | 0.23 ± 0.02 | 0.36 ± 0.02 | 1.33 ± 0.14 | 1.92 ± 0.14 | 4.4 ± 0.6 | −3.3 ± 0.5 |
| lPMH | −7.7 ± 0.9 | 50.5 ± 5.5 | −31.7 ± 3.2 | 82.2 ± 8.2 | 0.27 ± 0.06 | 0.33 ± 0.02 | 0.98 ± 0.05 | 1.57 ± 0.11 | 4.9 ± 0.6 | −5.0 ± 0.8 | |
| uPMH | −9.0 | −43.1 | 22.4 | 65.6 | 0.05 | 0.57 | 1.19 | 1.81 | 3.0 | −3.0 | |
| N1P1 | PMH | −0.7 ± 1.0 | −47.9 ± 6.9 | 35.1 ± 5.7 | 83.0 ± 12.5 | 0.04 ± 0.04 | 0.69 ± 0.06 | 1.45 ± 0.17 | 2.14 ± 0.24 | 2.5 ± 0.3 | −2.2 ± 0.4 |
| lPMH | −1.4 ± 0.8 | −36.5 ± 3.9 | 27.4 ± 2.2 | 63.9 ± 5.8 | 0.05 ± 0.03 | 0.62 ± 0.09 | 1.34 ± 0.05 | 1.99 ± 0.10 | 2.4 ± 0.5 | −1.8 ± 0.1 | |
| uPMH | 5.6 ± 1.5 | −29.2 ± 5.8 | 25.1 ± 2.5 | 54.4 ± 6.8 | 0.42 ± 0.09 | 0.51 ± 0.09 | 1.35 ± 0.14 | 2.29 ± 0.17 | 1.8 ± 0.7 | −2.4 ± 0.7 | |
| P1N1P2 | PMH | 0.5 | −58.5 | 38.1 | 96.6 | 0.09 | 0.70 | 1.53 | 2.23 | 2.61 | −2.2 |
| lPMH | 5.5 | −33.1 | 33.8 | 66.9 | 1.15 | 0.53 | 1.20 | 1.73 | 3.0 | −2.1 |
Asterisks of the same color (red or blue) indicate a significant difference for paired post-hoc Dunn’s test.
Analysis of the discharge pattern computed at the three regions.
| Region | Freqcell (Hz) | Freqraw (Hz) | BI | PI | PR |
|---|---|---|---|---|---|
| uPMH | 3.4 ± 0.6 | 6.4 ± 1.2 | 0.220 ± 0.038 | 1.612 ± 0.322 | 1.556 ± 0.724 |
| PMH | 6.1 ± 2.3 | 7.9 ± 1.9 | 0.176 ± 0.044 | 2.438 ± 1.108 | 0.606 ± 1.004 |
| lPMH | 7.1 ± 3.2 | 6.6 ± 1.5 | 0.225 ± 0.123 | 2.759 ± 0.708 | 2.360 ± 1.443 |
BI = burst index; Freqcell = unitary frequency by neuron; Freqraw = frequency for the raw trace; PI = pause index; PR = pause ratio.
Figure 3Probability mass functions for ISI distributions. (A) uPMH, (B) PMH and (C) lPMH. Dashed lines represent upper and lower ±2.5 × SEM. Bin = 10 ms. Mode in red and median in blue. The inset in (A) represents the double-exponential fitted functions for uPMH (red), PMH (green) and lPMH (blue).
Figure 4Atypical EAP obtained from raw recordings from (A) patients #1 (B) and #3. A small horizontal line under each trace is expanded in the trace immediately below. Values for horizontal calibration bars correspond to upper to lower traces.
Comparison between thalamic cells (obtained from a previous work) and hypothalamic cells.
| mAP | Region | N | dVmax | dVmin | VFP | VDep | VRep | VmAP | dFP | dDep | dRep | dmAP | Freqcell |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thalam. | 70 | 4.6 ± 0.4 | −4.0 ± 0.4 | - | 55.8 ± 4.6 | −21.9 ± 2.9 | 78.8 ± 7.2 | - | 0.43 ± 0.02 | 1.53 ± 0.9 | 1.99 ± 0.8 | 0.6 ± 0.1 | |
| P1N1 | Hypoth. | 55 | 3.2 ± 0.2 | −3.5 ± 0.2 | - | 45.9 ± 2.5 | −28.4 ± 1.5 | 74.3 ± 3.6 | - | 0.45 ± 0.01 | 1.10 ± 0.04 | 1.55 ± 0.04 | 1.3 ± 0.3 |
| Signif. | n.s. | n.s. | n.s. | 0.001 | n.s. | 0.05 | 0.001 | 0.001 | 0.001 | ||||
| Thalam. | 811 | 6.6 ± 0.2 | −6.3 ± 0.2 | 18.2 ± 0.6 | 95.3 ± 2.2 | −53.4 ± 1.1 | 148.8 ± 3.3 | 0.11 ± 0.00 | 0.38 ± 0.00 | 1.78 ± 0.01 | 2.83 ± 1.1 | 1.1 ± 0.1 | |
| P1P2N1 | Hypoth. | 29 | 2.5 ± 0.2 | −3.4 ± 0.3 | 13.7 ± 1.9 | 44.5 ± 3.8 | −30.6 ± 2.3 | 75.1 ± 5.9 | 0.27 ± 0.01 | 0.37 ± 0.01 | 1.15 ± 0.07 | 1.77 ± 0.07 | 1.6 ± 0.7 |
| Signif. | 0.001 | 0.001 | n.s. | 0.001 | 0.001 | 0.001 | 0.001 | n.s. | 0.001 | 0.001 | n.s. | ||
| Thalam. | 216 | 8.2 ± 0.4 | −6.1 ± 0.3 | −15.6 ± 0.7 | 85.2 ± 4.0 | −36.9 ± 1.9 | 122.1 ± 5.8 | 0.16 ± 0.00 | 0.36 ± 0.01 | 1.14 ± 0.01 | 1.66 ± 0.03 | 1.7 ± 0.3 | |
| N1P1N2 | Hypoth. | 53 | 4.7 ± 0.3 | −4.2 ± 0.3 | −8.7 ± 0.7 | 51.0 ± 3.9 | −30.9 ± 1.7 | 81.9 ± 5.2 | 0.27 ± 0.02 | 0.34 ± 0.01 | 1.12 ± 0.06 | 1.74 ± 0.07 | 1.3 ± 0.3 |
| Signif. | 0.001 | 0.001 | 0.001 | 0.001 | n.s. | 0.01 | 0.001 | 0.001 | 0.001 | n.s. | 0.001 | ||
| Thalam. | 17 | 8.5 ± 0.9 | −8.6 ± 0.8 | 6.9 ± 1.0 | −102.6 ± 10.9 | 46.4 ± 6.1 | 149.0 ± 16.2 | 0.08 ± 0.03 | 0.46 ± 0.06 | 1.98 ± 0.07 | 2.65 ± 0.12 | 2.5 ± 0.1 | |
| P1N1P2 | Hypoth. | 9 | 2.3 ± 0.3 | −2.3 ± 0.3 | 4.5 ± 1.1 | −36.5 ± 3.7 | 26.1 ± 1.3 | 62.6 ± 4.4 | 0.28 ± 0.07 | 0.56 ± 0.05 | 1.26 ± 0.08 | 2.06 ± 0.15 | 1.0 ± 0.6 |
| Signif. | 0.001 | 0.001 | n.s. | 0.001 | 0.01 | 0.001 | 0.001 | 0.001 | 0.001 | n.s. | 0.01 |
Hypoth. = hypothalamic; Thalam. = thalamic; Signif. = statistical significance, lower than the value indicated for the Mann-Whitney U test.